This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stock Under $10 that he thinks could potentially double or triple in the next 6 to 12-months. See what he's trading today with a 14-day FREE pass.

Insider Trading Alert - EBay And 4 Others Traded By Insiders

VCA Antech (WOOF) - FREE Research Report

ANTIN ARTHUR J who is COO & Senior Vice President at VCA ANTECH INC sold 32,613 shares at $25.08 per share for a total value of $817,934.04 on June 24, 2013. Following this transaction, the COO & Senior Vice President owned 534,827 shares meaning that the stake was reduced by 5.75% with the 32,613 share sell-off.

ANTIN ROBERT L who is CEO, President & Chairman at VCA ANTECH INC sold 65,225 shares at $25.08 per share for a total value of $1,635,843.00 on June 24, 2013. Following this transaction, the CEO, President & Chairman owned 2.6 million shares meaning that the stake was reduced by 2.47% with the 65,225 share sell-off.

Drake Josh who is President, Antech Diagnostics at VCA ANTECH INC sold 4,698 shares at $25.08 per share for a total value of $117,825.84 on June 24, 2013. Following this transaction, the President, Antech Diagnostics owned 55,242 shares meaning that the stake was reduced by 7.84% with the 4,698 share sell-off.

FULLER TOMAS W who is CFO, VP & Secretary at VCA ANTECH INC sold 11,274 shares at $25.08 per share for a total value of $282,751.92 on June 24, 2013. Following this transaction, the CFO, VP & Secretary owned 246,470 shares meaning that the stake was reduced by 4.37% with the 11,274 share sell-off.

TAUBER NEIL who is Senior VP at VCA ANTECH INC sold 10,335 shares at $25.08 per share for a total value of $259,201.80 on June 24, 2013. Following this transaction, the Senior VP owned 158,288 shares meaning that the stake was reduced by 6.13% with the 10,335 share sell-off.

The shares most recently traded at $25.85, up $0.10, or 0.39% since the insider transactions. Historical insider transactions for VCA Antech go as follows:

  • 4-Week # shares sold: 6,673
  • 12-Week # shares sold: 6,673
  • 24-Week # shares sold: 8,237

The average volume for VCA Antech has been 757,600 shares per day over the past 30 days. VCA Antech has a market cap of $2.2 billion and is part of the services sector and diversified services industry. Shares are up 22.33% year to date as of the close of trading on Thursday.

VCA Antech, Inc. operates as an animal healthcare company in the United States and Canada. It operates through two segments, Animal Hospital and Laboratory. The company has a P/E ratio of 58.6. Currently there are 4 analysts that rate VCA Antech a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WOOF - FREE

TheStreet Quant Ratings rates VCA Antech as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full VCA Antech Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
Submit an article to us!

Markets

DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs